Aug 18 (Reuters) - Biofrontera AG B8FGn.DE :
* PTA-NEWS: BIOFRONTERA AG: BIOFRONTERA REPORTS FINANCIAL
RESULTS
FOR THE SIX MONTHS ENDED JUNE 30, 2022
* TOTAL SALES OF EUR 15,076 THOUSAND IN PERIOD FROM JANUARY
1 TO
JUNE 30, 2022, VERSUS EUR 13,094 THOUSAND IN FIRST HALF OF 2021
* BIOFRONTERA- CONTINUES TO EXPECT SALES OF EUR 24 TO 27
MILLION,
ALMOST BREAK-EVEN EBITDA, NEGATIVE EBIT IN LOW SINGLE-DIGIT
MILLION RANGE FOR FY 2022
* GROUP EBITDA IMPROVED BY EUR 9,135 THOUSAND TO EUR 3,367
THOUSAND IN FIRST HALF OF 2022 COMPARED WITH PRIOR-YEAR PERIOD
* H1 2022 EBIT EUR 2,990 THOUSAND (PRIOR-YEAR PERIOD: EUR
-7,391
THOUSAND)
Source text for Eikon: ID:nPexqrfQRa
Further company coverage: B8FGn.DE
((Reuters.Briefs@thomsonreuters.com;))